[HTML][HTML] Occupational exposures and exacerbations of asthma and COPD—a general population study
S Skaaby, EM Flachs, P Lange, V Schlünssen… - PLoS …, 2020 - journals.plos.org
Purpose Recent studies suggest that occupational inhalant exposures trigger exacerbations
of asthma and chronic obstructive pulmonary disease, but findings are conflicting. Methods …
of asthma and chronic obstructive pulmonary disease, but findings are conflicting. Methods …
Insights into interventions in managing COPD patients: lessons from the TORCH and UPLIFT® studies
M Miravitlles, A Anzueto - International journal of chronic …, 2009 - Taylor & Francis
Influencing the progression of COPD has long been an elusive goal of drug therapy. Directly
or indirectly, this has again been investigated in two of the largest, long-term drug trials in …
or indirectly, this has again been investigated in two of the largest, long-term drug trials in …
Tratamiento individualizado de la EPOC: una propuesta de cambio
M Miravitlles - Archivos de Bronconeumología, 2009 - Elsevier
La enfermedad pulmonar obstructiva crónica (EPOC) es una enfermedad muy prevalente,
pero, en contraste, carece de una adecuada definición y existe una gran confusión en …
pero, en contraste, carece de una adecuada definición y existe una gran confusión en …
[HTML][HTML] Airflow reversibility and long-term outcomes in patients with COPD without comorbidities
JM Marín, M Ciudad, V Moya, S Carrizo, S Bello… - Respiratory …, 2014 - Elsevier
Background The forced expiratory volume at first second (FEV 1) during spirometry reflects
the severity of chronic obstructive pulmonary disease (COPD) and is known to be an …
the severity of chronic obstructive pulmonary disease (COPD) and is known to be an …
Inhaled albuterol/salbutamol and ipratropium bromide and their combination in the treatment of chronic obstructive pulmonary disease
J Gordon, RJ Panos - Expert opinion on drug metabolism & …, 2010 - Taylor & Francis
Importance of the field: Chronic obstructive pulmonary disease (COPD) is a major cause of
morbidity and mortality throughout the world. Combination therapy with albuterol and …
morbidity and mortality throughout the world. Combination therapy with albuterol and …
[HTML][HTML] Prediction of long-term benefits of inhaled steroids by phenotypic markers in moderate-to-severe COPD: a randomized controlled trial
JB Snoeck-Stroband, TS Lapperre, PJ Sterk… - PLoS …, 2015 - journals.plos.org
Background The decline in lung function can be reduced by long-term inhaled corticosteroid
(ICS) treatment in subsets of patients with chronic obstructive pulmonary disease (COPD) …
(ICS) treatment in subsets of patients with chronic obstructive pulmonary disease (COPD) …
Which patients with chronic obstructive pulmonary disease benefit from the addition of an inhaled corticosteroid to their bronchodilator? A cluster analysis
RL DiSantostefano, H Li, DB Rubin, DA Stempel - BMJ open, 2013 - bmjopen.bmj.com
Objective To identify subsets of chronic obstructive pulmonary disease (COPD) patients who
are more protected from exacerbations with the use of an inhaled corticosteroid/long-acting …
are more protected from exacerbations with the use of an inhaled corticosteroid/long-acting …
[HTML][HTML] The overlap phenotype: the (missing) link between asthma and COPD
B Piras, M Miravitlles - Multidisciplinary respiratory medicine, 2012 - Springer
The definition of chronic obstructive pulmonary disease (COPD) as a preventable and
treatable condition characterized by a not completely reversible chronic airflow obstruction …
treatable condition characterized by a not completely reversible chronic airflow obstruction …
[HTML][HTML] Bronchodilator responsiveness and onset of effect with budesonide/formoterol pMDI in COPD
BR Celli, DP Tashkin, SI Rennard, J McElhattan… - Respiratory …, 2011 - Elsevier
BACKGROUND: Chronic obstructive pulmonary disease (COPD) patients are thought to
have limited bronchodilator response, determined by changes in forced expiratory volume in …
have limited bronchodilator response, determined by changes in forced expiratory volume in …
Systematic approach to asthma of varying severity
S Khurana, NN Jarjour - Clinics in Chest Medicine, 2019 - chestmed.theclinics.com
Asthma is a serious global health issue affecting 235 million people worldwide. 1
Approximately 25 million people suffer from asthma in the United States, and 47% reported …
Approximately 25 million people suffer from asthma in the United States, and 47% reported …